Publication Cover
Redox Report
Communications in Free Radical Research
Volume 22, 2017 - Issue 6
1,982
Views
14
CrossRef citations to date
0
Altmetric
Original Articles

The role of the saliva antioxidant barrier to reactive oxygen species with regard to caries development

, , , , &

Figures & data

Figure 1. Antioxidants’ contribution in regulation and mechanism of action of cariogenic bacteria. Response of S. mutans to oxidative stress caused by ROS produced by neutrophils, fibroblasts, and other cells of the oral cavity is accompanied by, e.g. increased response from the bacterial enzymatic systems as intracellular NADH oxidase (Nox) in the SpxA1/ SpxB/ Rex-dependent modulation, and proteins that affect cellular redox status and are involved in the regulation of S. mutans’s metabolism. Antioxidant systems of the host (e.g. salivary GSH, GSSG, TAC) and exogenous factors (e.g. diet and hygienic habits) act in addition to antioxidant systems of bacteria.

Figure 1. Antioxidants’ contribution in regulation and mechanism of action of cariogenic bacteria. Response of S. mutans to oxidative stress caused by ROS produced by neutrophils, fibroblasts, and other cells of the oral cavity is accompanied by, e.g. increased response from the bacterial enzymatic systems as intracellular NADH oxidase (Nox) in the SpxA1/ SpxB/ Rex-dependent modulation, and proteins that affect cellular redox status and are involved in the regulation of S. mutans’s metabolism. Antioxidant systems of the host (e.g. salivary GSH, GSSG, TAC) and exogenous factors (e.g. diet and hygienic habits) act in addition to antioxidant systems of bacteria.

Figure 2. Morphological assessment of Streptococcus sp. bacteria. Photograph shows macro- and micromorphology of Streptococcus sp. 1 – S. mutans colonies with characteristic white coloration on the tested medium; 2 – on blood agar (BA); 3 – S. mutans cells in Gram-stained preparation. Photograph 3 taken with an Olympus CX41 microscope, coupled to a CaMedia C5550 camera; 4 – S. mutans cells in a JEOL JSM-35CF SEM.

Figure 2. Morphological assessment of Streptococcus sp. bacteria. Photograph shows macro- and micromorphology of Streptococcus sp. 1 – S. mutans colonies with characteristic white coloration on the tested medium; 2 – on blood agar (BA); 3 – S. mutans cells in Gram-stained preparation. Photograph 3 taken with an Olympus CX41 microscope, coupled to a CaMedia C5550 camera; 4 – S. mutans cells in a JEOL JSM-35CF SEM.

Figure 3. The percentage share of individual bacterial strains isolated from saliva of children with cavitated ECC, non-cavitated ECC, and children without symptoms of the disease.

Figure 3. The percentage share of individual bacterial strains isolated from saliva of children with cavitated ECC, non-cavitated ECC, and children without symptoms of the disease.

Figure 4. (a). Salivary reduced-glutathione levels in all groups with ECC and in the control group. The median and interquartile range (box), and percentile 5–95% range (whiskers) are shown; P-values are given for the comparison of groups with each other (***P < 0.001 post-hoc Mann–Whitney test with Bonferroni correction). Cavitated patients with ECC; non-cavitated patients with ECC; control without lesions. (b). Salivary GSSG levels in all groups with ECC and in the control group. The median and interquartile range (box), and percentile 5–95% range (whiskers) are shown; P-values are given for the comparison of groups with each other (***P < 0.001 post-hoc Mann-–Whitney test with Bonferroni correction). Cavitated patients with ECC; non-cavitated patients with ECC; control without lesions. (c). Salivary TAC levels in all groups with ECC and in the control group. The median and interquartile range (box), and percentile 5–95% range (whiskers) are shown; P-values are given for the comparison of groups with each other (***P < 0.001 post hoc Mann–Whitney test with Bonferroni correction). Cavitated patients with ECC; non-cavitated patients with ECC; control without lesions.

Figure 4. (a). Salivary reduced-glutathione levels in all groups with ECC and in the control group. The median and interquartile range (box), and percentile 5–95% range (whiskers) are shown; P-values are given for the comparison of groups with each other (***P < 0.001 post-hoc Mann–Whitney test with Bonferroni correction). Cavitated patients with ECC; non-cavitated patients with ECC; control without lesions. (b). Salivary GSSG levels in all groups with ECC and in the control group. The median and interquartile range (box), and percentile 5–95% range (whiskers) are shown; P-values are given for the comparison of groups with each other (***P < 0.001 post-hoc Mann-–Whitney test with Bonferroni correction). Cavitated patients with ECC; non-cavitated patients with ECC; control without lesions. (c). Salivary TAC levels in all groups with ECC and in the control group. The median and interquartile range (box), and percentile 5–95% range (whiskers) are shown; P-values are given for the comparison of groups with each other (***P < 0.001 post hoc Mann–Whitney test with Bonferroni correction). Cavitated patients with ECC; non-cavitated patients with ECC; control without lesions.

Table 1. Adjusted relationships between reduced glutathione, oxidized glutathione and TAC and salivary bacterial profiles and dental caries progression.

Table 2. Relationship between salivary glutathione and TAC levels, and salivary bacterial profiles and dental caries.

Figure 5. Scatterplots of the relationship between change in (a) GSH and age, (b) GSSG and age, and (c) TAC and age.

Figure 5. Scatterplots of the relationship between change in (a) GSH and age, (b) GSSG and age, and (c) TAC and age.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.